1
|
Beitl K, Ott J, Rosta K, Holzer I, Foessleitner P, Steininger J, Panay N. Premature ovarian insufficiency and autoimmune profiles: a prospective case-control study. Climacteric 2024; 27:187-192. [PMID: 38108204 DOI: 10.1080/13697137.2023.2287631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2023] [Accepted: 11/14/2023] [Indexed: 12/19/2023]
Abstract
OBJECTIVE Autoimmunity seems to be present in a large proportion of women with spontaneous premature ovarian insufficiency (POI). Whether these women are at increased risk for autoimmune disease has not been determined to date. Therefore, the aim of this study was to investigate a large series of antibodies in order to shed more light into the autoimmune risk of POI women. METHODS In a prospective case-control study, blood samples from 66 patients with spontaneous POI and 66 healthy controls were analyzed for a series of autoimmune antibodies. RESULTS POI women revealed significantly increased thyroglobulin antibodies (TGAb) (p = 0.045) and thyroid peroxidase antibodies (TPOAb) (p = 0.002). At least one abnormal autoimmune parameter was present in 37.9% of POI women, compared to 18.2% in healthy controls (p = 0.045). A strong association between POI and increased TGAb (adjusted odds ratio 3.586, p = 0.028), increased TPOAb (adjusted odds ratio 7.496, p = 0.003) and any increased autoimmune parameter (adjusted odds ratio 3.189, p = 0.008) could be demonstrated in a binary logistic regression model. CONCLUSION A high prevalence of autoimmunity in POI women compared to a healthy young collective could be demonstrated. Thyroid antibodies were significantly increased in POI women. Our data highlight the increased risk for autoimmune diseases, especially for thyroid disorders.
Collapse
Affiliation(s)
- K Beitl
- Clinical Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
| | - J Ott
- Clinical Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
| | - K Rosta
- Clinical Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
| | - I Holzer
- Clinical Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
| | - P Foessleitner
- Clinical Division of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, Vienna, Austria
| | - J Steininger
- Clinical Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
| | - N Panay
- Department of Gynaecology, Imperial College Healthcare, NHS Trust, London, UK
| |
Collapse
|
2
|
Ozsvári-Vidákovich M, Somogyi A, Rosta K. [Association between intrahepatic cholestasis of pregnancy and gestational diabetes mellitus]. Orv Hetil 2023; 164:831-835. [PMID: 37245205 DOI: 10.1556/650.2023.32778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2023] [Accepted: 03/18/2023] [Indexed: 05/30/2023]
Abstract
Gestational diabetes mellitus is one of the most prevalent prenatal illnesses (ranging from 5% to 18%), while intrahepatic cholestasis of pregnancy takes the first place among liver diseases during pregnancy (ranging from 0.2% to 27%). In our summary, we examined the relationship between the two gestation-related medical conditions and their combined presence affects on the outcome of pregnancy. Based on research available, it can be stated that intrahepatic cholestasis of pregnancy may be a predisposing factor to late-onset gestational diabetes mellitus. This connection stems from the modulating role of serum bile acids, as due to the regulation of farnesoid X receptor and Takeda G protein-coupled receptor 5 the bile acids affect glucose and lipid homeostasis. Common fetal complications of gestational diabetes and intrahepatic cholestasis of pregnancy are stillbirth, acute respiratory distress syndrome and preterm delivery. Gestational diabetes mellitus may be more common in patients with intrahepatic cholestasis of pregnancy, and the co-occurrence of the two diseases can increase the risk of fetal and maternal complications, therefore special attention must be paid to the prevention and treatment of these by the prenatal caregiver. Orv Hetil. 2023; 164(21): 831-835.
Collapse
Affiliation(s)
- Magdolna Ozsvári-Vidákovich
- 1 Dél-budai Centrumkórház - Szent Imre Egyetemi Oktatókórház, Szülészeti és Nőgyógyászati Osztály Budapest Magyarország
| | - Anikó Somogyi
- 2 Semmelweis Egyetem, Általános Orvostudományi Kar, Belgyógyászati és Hematológiai Klinika Budapest Magyarország
| | - Klára Rosta
- 3 Bécsi Orvostudományi Egyetem, Szülészeti és Nőgyógyászati Klinika 18-20 Währinger Gürtel, A-1090 Wien Ausztria
| |
Collapse
|
3
|
Mészáros B, Veres DS, Nagyistók L, Somogyi A, Rosta K, Herold Z, Kukor Z, Valent S. Pravastatin in preeclampsia: A meta-analysis and systematic review. Front Med (Lausanne) 2023; 9:1076372. [PMID: 36714131 PMCID: PMC9880057 DOI: 10.3389/fmed.2022.1076372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Accepted: 12/30/2022] [Indexed: 01/15/2023] Open
Abstract
Objective To review of the efficacy and safety of pravastatin use for prophylaxis and treatment of preeclampsia. Design Systematic review and meta-analysis of clinical studies evaluating pravastatin for treatment and/or prophylaxis of preeclampsia. Data collection Two independent reviewers systematically searched data from PubMed, Scopus, Web of Science, Cochrane, Embase, and clinicaltrials.gov databases, for studies evaluating pravastatin for prevention of pre-eclampsia. Results Fourteen studies were identified, including 1,570 pregnant women who received either pravastatin or placebo, published between 2003 and 2022. From these studies, 5 studies were identified for inclusion in the meta-analysis to evaluate the role of pravastatin use prior to 20 weeks of gestation, to prevent pre-eclampsia, Pravastatin treatment reduced the incidence of preeclampsia by 61% and premature birth by 45%. Among the newborns, there was a 45% reduction in intrauterine growth retardation (IUGR) in the treated group, as well as a 77% reduction in those receiving neonatal intensive care unit (NICU) admissions. Conclusion Prophylactic treatment with pravastatin appears to reduce risk of developing pre-eclampsia as well as potentially lowering risk of IUGR, preterm birth, and NICU admission in neonates.
Collapse
Affiliation(s)
- Balázs Mészáros
- Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary
| | - Dániel Sándor Veres
- Department of Biophysics and Radiation Biology, Semmelweis University, Budapest, Hungary
| | - Luca Nagyistók
- Dél-Pest Centrum Hospital National Hematology and Infectious Diseases Institute, Budapest, Hungary
| | - Anikó Somogyi
- Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary
| | - Klára Rosta
- Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
| | - Zoltán Herold
- Division of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary
| | - Zoltán Kukor
- Department of Molecular Biology, Institute of Biochemistry and Molecular Biology, Semmelweis University, Budapest, Hungary,*Correspondence: Zoltán Kukor,
| | - Sándor Valent
- Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary
| |
Collapse
|
4
|
Puchner A, Rosenberg N, Valenta N, Ritschl V, Stamm T, Mandl P, Aletaha D, Rosta K. AB1177 SEXUALITY, FAMILY PLANNING AND MENTAL HEALTH AMONG REPRODUCTIVE-AGE WOMEN WITH RHEUMATIC DISEASE DURING THE COVID-19 PANDEMIC. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.4937] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundWomen with rheumatic disease are more likely to suffer from sexual dysfunction, infertility, depression, and anxiety. The pandemic may have affected these constraints.ObjectivesTo investigate the effect of the Covid-19 pandemic on sexuality, family planning and mental health in a sample of women with rheumatic disease.MethodsWomen aged 18-50 with a rheumatic disease and women in an age-matched healthy control group received questionnaires featuring: 1) demographic information, sexual frequency, family planning; 2) the Female Sexual Function Index (FSFI); 3) the Depression, Anxiety and Stress Scale (DASS-21); and 4) the Coronavirus Anxiety Scale (CAS). Recruitment took place 3/21-12/21. Patients with rheumatic conditions were recruited at the Vienna University Clinic (AKH) and the control group through social media. Parameters were compared between the patients and the healthy control group, and with data on sexuality from women with rheumatic disease from 2019.ResultsA preliminary analysis was conducted with 83 patients with rheumatic disease and 124 healthy controls. The rheumatic disease group exhibited lower levels of stress (6.46 vs. 8.36 p<0.01) and Coronavirus Anxiety (6.27 vs 7.50 p<0.01) than the control group and was less likely to report that the pandemic led to a reduction of their sexual frequency (p<0.01). The control group cited “stress” frequently the decrease of sexual frequency. The FSFI analysis revealed that patients with rheumatic disease experienced higher levels of pain (p<0.001) during sex than the control group but were more satisfied with their relationships (p<0.05). In comparison to 58 patients with rheumatic conditions, whose data was collected in 2019, the 2021 cohort reported reduced FSFI values in the domains of desire (p<0.01), arousal (p<0.05), lubrication (p<0.05), and orgasms (p<0.01).ConclusionConsistent with research on female sexuality during the pandemic among healthy women, we found that patients with rheumatic conditions reported lower FSFI values in 2021, in comparison to 2019. Our finding that the pandemic had less impact on the patient group than a healthy control group, is consistent with research on MS and IBD patients, who showed surprising resilience in the face of the Covid-19 pandemic.Disclosure of InterestsNone declared
Collapse
|
5
|
Rosenberg N, Mazzucato-Puchner AB, Valenta N, Stamm T, Rosta K. Sexualität, Familienplanung und psychische Gesundheit bei Frauen im gebärfähigen Alter mit rheumatischen Erkrankungen während der Covid-19 Pandemie. Geburtshilfe Frauenheilkd 2022. [DOI: 10.1055/s-0042-1750216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
Affiliation(s)
- N Rosenberg
- Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| | - A B Mazzucato-Puchner
- Klinische Abteilung für Rheumatologie, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien
| | - N Valenta
- Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| | - T Stamm
- Zentrum für Medizinische Statistik, Informatik und Intelligente Systeme, Medizinische Universität Wien
| | - K Rosta
- Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| |
Collapse
|
6
|
Zwick C, Hütter L, Mazzucato-Puchner A, Redlich K, Sevelda P, Rosta K. Lupus, das Chamäleon. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1713230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
Affiliation(s)
- C Zwick
- KH Hietzing, Abteilung für Gynäkologie und Geburtshilfe, Wien
| | - L Hütter
- KH Hietzing, 2. Medizinische Abteilung (Rheumatologie), Wien
| | | | - K Redlich
- KH Hietzing, 2. Medizinische Abteilung (Rheumatologie), Wien
| | - P Sevelda
- KH Hietzing, Abteilung für Gynäkologie und Geburtshilfe, Wien
| | - K Rosta
- Universitätsklinik für Gynäkologie und Geburtshilfe, Wien
| |
Collapse
|
7
|
Valenta N, Mrak D, Puchner A, Rosta K. Sexualität und Verhütungsmethoden von Patientinnen mit einer rheumatischen Erkrankung. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1713200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
Affiliation(s)
- N Valenta
- Abteilung für Geburtshilfe und fetomaternale Medizin, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| | - D Mrak
- Universitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie, Medizinische Universität Wien
| | - A Puchner
- Abteilung für Geburtshilfe und fetomaternale Medizin, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| | - K Rosta
- Abteilung für Geburtshilfe und fetomaternale Medizin, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| |
Collapse
|
8
|
Mair K, Mazzucato-Puchner A, Mandl P, Rosta K. Management der hämophagozytären Lymphohistiozytose in der Schwangerschaft. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1713224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
Affiliation(s)
- K Mair
- Abteilung für Geburtshilfe und fetomaternale Medizin, Universitätsklinik für Frauenheilkunde Medizinische Universität Wien
| | - A Mazzucato-Puchner
- Universitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie, Medizinische Universität Wien
| | - P Mandl
- Universitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie, Medizinische Universität Wien
| | - K Rosta
- Abteilung für Geburtshilfe und fetomaternale Medizin, Universitätsklinik für Frauenheilkunde Medizinische Universität Wien
| |
Collapse
|
9
|
Falcone V, Reischer T, Springer S, Husslein PW, Rosta K. Beta Thalassemia minor and its impact on glucose metabolism during pregnancy: a retrospective study to assess implication for mothers and offspring. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1713213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
Affiliation(s)
- V Falcone
- Department of obstetrics and gynecology, Medical University of Vienna
| | - T Reischer
- Department of obstetrics and gynecology, Medical University of Vienna
| | - S Springer
- Department of obstetrics and gynecology, Medical University of Vienna
| | - P W Husslein
- Department of obstetrics and gynecology, Medical University of Vienna
| | - K Rosta
- Department of obstetrics and gynecology, Medical University of Vienna
| |
Collapse
|
10
|
Rosta K, Mrak D, Valenta N, Stamm T, Ritschl V, Husslein P, Puchner A. Preliminary Results from the Nationwide Austrian Register for Reproduction and Rheumatic Disease (RhePro Register). Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1713225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
Affiliation(s)
- K Rosta
- Abteilung für Geburtshilfe und fetomaternale Medizin, Universitätsklinik für Frauenheilkunde Medizinische Universität Wien
| | - D Mrak
- Universitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie, Medizinische Universität Wien
| | - N Valenta
- Abteilung für Geburtshilfe und fetomaternale Medizin, Universitätsklinik für Frauenheilkunde Medizinische Universität Wien
| | - T Stamm
- Zentrum für Medizinische Statistik, Informatik und Intelligente Systeme, Medizinische Universität Wien
| | - V Ritschl
- Zentrum für Medizinische Statistik, Informatik und Intelligente Systeme, Medizinische Universität Wien
| | - P Husslein
- Abteilung für Geburtshilfe und fetomaternale Medizin, Universitätsklinik für Frauenheilkunde Medizinische Universität Wien
| | - A Puchner
- Universitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie, Medizinische Universität Wien
| |
Collapse
|
11
|
Rosta K, Bancher-Todesca D, Hadarits O, Al-Aissa Z, Kautzky-Willer A, Firneisz G. Neue Aspekte in der Entwicklung des Gestationsdiabetes: Eine Studie an 77 einzelnen Nucleotid-Gen-Polymorphismen in der Schwangerschaft. Geburtshilfe Frauenheilkd 2017. [DOI: 10.1055/s-0037-1602339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Affiliation(s)
- K Rosta
- Abteilung für Geburtshilfe und Fetomaternale Medizin, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| | - D Bancher-Todesca
- Abteilung für Geburtshilfe und Fetomaternale Medizin, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| | - O Hadarits
- Abteilung für Geburtshilfe und Fetomaternale Medizin, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| | - Z Al-Aissa
- Abteilung für Geburtshilfe und Fetomaternale Medizin, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| | - A Kautzky-Willer
- Abteilung für Geburtshilfe und Fetomaternale Medizin, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| | - G Firneisz
- Abteilung für Geburtshilfe und Fetomaternale Medizin, Universitätsklinik für Frauenheilkunde, Medizinische Universität Wien
| |
Collapse
|
12
|
Al-Aissa Z, Hadarits O, Rosta K, Zóka A, Rigó J, Firneisz G, Somogyi A. [A brief of gestational diabetes mellitus, risk factors and current criteria of diagnosis]. Orv Hetil 2017; 158:283-290. [PMID: 28218564 DOI: 10.1556/650.2017.30651] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Diabetes is one of the most common metabolic disorders that may cause pathological pregnancy. Treating diabetes recognized during pregnancy results in lowering maternal and fetal complications. These patients present higher risk for excessive weight gain, preeclampsia, delivery with cesarean sections, high risk of developing type 2 diabetes and cardiovascular disease in the future. Fetuses of mothers with gestational diabetes are at higher risk for macrosomia and birth trauma, after delivery they present higher risk of developing neonatal hypoglycemia, hyperbilirubinemia, and respiratory distress syndrome. There is still no consensus in the recommendations for the diagnosis of gestational diabetes mellitus by expert committees. Orv. Hetil., 2017, 158(8), 283-290.
Collapse
Affiliation(s)
- Zahra Al-Aissa
- II. Belgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest, Szentkirályi utca 46., 1088
| | - Orsolya Hadarits
- Szülészeti és Nőgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest
| | - Klára Rosta
- Szülészeti és Nőgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest.,Szülészeti és Nőgyógyászati Klinika, Bécsi Orvostudományi Egyetem Bécs
| | - András Zóka
- Szent István és Szent László Kórház-Rendelőintézet Budapest
| | - János Rigó
- Szülészeti és Nőgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest
| | - Gábor Firneisz
- II. Belgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest, Szentkirályi utca 46., 1088.,MTA-SE Molekuláris Medicina Kutatócsoport Budapest
| | - Anikó Somogyi
- II. Belgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest, Szentkirályi utca 46., 1088
| |
Collapse
|
13
|
Hadarits O, Zóka A, Barna G, Al-Aissa Z, Rosta K, Rigó J, Kautzky-Willer A, Somogyi A, Firneisz G. Increased Proportion of Hematopoietic Stem and Progenitor Cell Population in Cord Blood of Neonates Born to Mothers with Gestational Diabetes Mellitus. Stem Cells Dev 2015; 25:13-7. [PMID: 26494027 PMCID: PMC4692114 DOI: 10.1089/scd.2015.0203] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
We assessed the hematopoietic stem and progenitor cell (HSPC) population in the cord blood of neonates born to mothers with gestational diabetes mellitus (GDM) in a hypothesis generating pilot study, due to that, neonatal polycythemia may be the consequence of GDM pregnancy. Forty-five pregnant women with GDM (last trimester mean HbA1C = 33.9 mmol/mol) and 42 (nondiabetic) control pregnant women were enrolled after their routine 75 g oral glucose tolerance test (OGTT) between the 24th and 28th gestational week (with expected differences in their mean routine clinical characteristics: plasma glucose at OGTT: 0′ = 5.07 vs. 4.62 mM, 120′ = 8.9 vs. 5.76 mM, age = 35.07 vs. 31.66 years, prepregnancy body mass index = 27.9 vs. 23.9 kg/m2, GDM vs. control, respectively) on a voluntary basis after signing the informed consent. EDTA-treated cord blood samples were analyzed by flow cytometry and the software Kaluza1.2 using CD45 and CD34-specific fluorescent antibodies to identify the HSPC population (CD34+ cells within the CD45dim blast gate). The proportion of CD34+CD45dim HSPCs among the nucleated cells was significantly (P < 0.05, statistical power = 60.8%) higher in the cord blood samples of neonates born to mothers with GDM (median 0.38%) compared to neonates born to nondiabetic mothers (median 0.32%) and according to treatment types (P < 0.05) median: control 0.32%, GDM-diet only 0.37%, GDM-on insulin 0.45%; control versus GDM on insulin (P < 0.05). The increased proportion of circulating CD34+CD45dim cells in the cord blood may possibly be related to altered fetal stem cell mobilization in GDM pregnancy, yet these results should be interpreted only as preliminary due to the small sample sizes.
Collapse
Affiliation(s)
- Orsolya Hadarits
- 1 1st Department of Obstetrics and Gynecology, Semmelweis University , Budapest, Hungary
| | - András Zóka
- 2 2nd Department of Internal Medicine, Semmelweis University , Budapest, Hungary
| | - Gábor Barna
- 3 1st Department of Pathology and Experimental Cancer Research, Semmelweis University , Budapest, Hungary
| | - Zahra Al-Aissa
- 2 2nd Department of Internal Medicine, Semmelweis University , Budapest, Hungary
| | - Klára Rosta
- 1 1st Department of Obstetrics and Gynecology, Semmelweis University , Budapest, Hungary .,4 Department of Obstetrics and Fetomaternal Medicine, University Hospital , Vienna, Austria
| | - János Rigó
- 1 1st Department of Obstetrics and Gynecology, Semmelweis University , Budapest, Hungary
| | - Alexandra Kautzky-Willer
- 5 Division of Endocrinology and Metabolism, Department of Medicine 3, Medical University of Vienna , Vienna, Austria
| | - Anikó Somogyi
- 2 2nd Department of Internal Medicine, Semmelweis University , Budapest, Hungary
| | - Gábor Firneisz
- 2 2nd Department of Internal Medicine, Semmelweis University , Budapest, Hungary .,6 Hungarian Academy of Sciences, Semmelweis University , Molecular Medicine Research Group, Budapest, Hungary
| |
Collapse
|
14
|
Al-Aissa Z, Rosta K, Hadarits O, Harreiter J, Zóka A, Bancher-Todesca D, Patócs A, Kiss K, Sármán B, Pusztai P, Sziller I, Rigó J, Rácz K, Somogyi A, Kautzky-Willer A, Firneisz G. Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes. Eur J Clin Invest 2015; 45:196-203. [PMID: 25556541 DOI: 10.1111/eci.12397] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/11/2014] [Accepted: 12/28/2014] [Indexed: 12/15/2022]
Abstract
BACKGROUND Tissue-specific dipeptidyl-peptidase 4 (DPP4) dysregulation has been described in adults with diabetes mellitus. The DPP4 -incretin system has not been studied in foetal life. In this study, DPP4 activity and glucagon-like peptide-1 (GLP-1) levels were assessed in cord blood of neonates born to women with gestational diabetes mellitus (GDM) and nondiabetic controls. MATERIAL AND METHODS This study has been conducted in two Hungarian and one Austrian centres. PATIENTS A total of 568 pregnant women were enrolled in the study after their OGTT between the 24th and 28th gestational week. Cord blood samplings with DPP4 activity and GLP-1 level measurements were possible in 270 (DPP4: 159 control, 111 GDM) and 112 (GLP-1: 72 control, 40 GDM) cases. OGTT (24-28th gestational week) and cord blood sampling at delivery were performed. Cord serum DPP4 activity was determined in a continuous monitoring microplate-based kinetic assay, and cord plasma GLP-1 was measured using a fluorescence ELISA method. RESULTS Cord serum DPP4 activity was lower in GDM [mean (95% CI): 28.07 U/L (26.32-29.82 U/L)] than in controls [31.61 U/L (29.93-33.29 U/L), MWU P = 0.0015]. Cord plasma active GLP-1 levels were close to the lower detection limit and were not altered in GDM (control: mean = 3.43 pM, 95% CI: 3.04-3.82 pM, GDM: mean = 3.61 pM, 95% CI: 2.96-4.28 pM - MWU test P = 0.6). CONCLUSIONS Decreased cord serum DPP4 activity in gestational diabetes mellitus might be the result of an adaptive foetal response or an early dysregulation in the entero-insular axis with consequences beyond the incretin system. Cord plasma GLP-1 levels may reflect the missing oral intake with a limited glucose sensing of L cells via the circulation in foetal life.
Collapse
Affiliation(s)
- Zahra Al-Aissa
- 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Rosta K, Hadarits O, Al-Aissa Z, List A, Feichtinger M, Sziller I, Rigo J, Somogyi A, Firneisz G, Kautzky-Willer A, Harreiter J, Bancher-Todesca D. VEGF und IL1RA Konzentrationen im Nabelschnurserum von Frauen mit Gestationsdiabetes. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
16
|
Rosta K, Al-Aissa Z, Hadarits O, Zóka A, Harreiter J, Kautzky-Willer A, Rigó J, Sziller I, Somogyi A, Bancher-Todesca D, Firneisz G. Erniedrigte fetale Dipeptidylpeptidase 4 (DPP4) Aktivität bei Gestationsdiabetes. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
17
|
Abstract
INTRODUCTION Hearing impairment is one of the most frequent chronic health issue. The incidence of hearing impairment and tinnitus increases with age. AIM The aim of the authors was to determine the prevalence of hearing impairment and tinnitus in type 2 diabetic patients and to examine the possible associations between hearing impairment and/or tinnitus and increased HbA1c levels. METHODS 103 patients with type 2 diabetes (47 men, 56 women; age, 61.6±10.3 years, mean±SD; range, 33-88 years) evaluated at the 2nd Department of Medicine, Semmelweis University were enrolled in this study and the results were compared to those obtained from 589 type 2 diabetic (253 men, 336 women; age, 55.4±11.0 years, mean±SD; range, 26-97 years) and 15 622 non-diabetic patients (7002 men, 8620 women; age, 55.1±11.1 years, mean±SD; range, 26-98 years) who participated in a comprehensive health screening programme in Hungary. Hearing impairment was determined using the Interacoustics model AS608 screening audiometer in all patient groups. Tinnitus was evaluated with questionnaire. RESULTS It was found that hearing impairment and/or tinnitus occurred in a very high proportion of type 2 diabetic patients evaluated at the 2nd Department of Medicine, Semmelweis University (80% of cases) as compared to type 2 diabetic (34% of cases) and non-diabetic patients (14% of cases) enrolled in the national health screening programme. There was no significant correlation between increased HbA1c levels and hearing impairment or tinnitus in type 2 diabetic patients. CONCLUSION These results suggest that the prevalence of hearing impairment and tinnitus is higher and develop at an earlier age in patients with type 2 diabetes. The results indicate a high prevalence of hearing impairment and tinnitus in type 2 diabetic patients.
Collapse
Affiliation(s)
- Anikó Somogyi
- Semmelweis Egyetem, Általános Orvostudományi Kar, II. Belgyógyászati Klinika, Budapest.
| | | | | |
Collapse
|
18
|
Vastagh I, Horváth T, Garamvölgyi Z, Rosta K, Folyovich A, Rigó J, Kollai M, Bereczki D, Somogyi A. Preserved structural and functional characteristics of common carotid artery in properly treated normoglycemic women with gestational diabetes mellitus. ACTA ACUST UNITED AC 2011; 98:294-304. [PMID: 21893468 DOI: 10.1556/aphysiol.98.2011.3.6] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
Women with gestational diabetes mellitus (GDM) are at high risk of subsequently developing type 2 diabetes mellitus which is an important cardiovascular risk factor. We have evaluated whether preclinical morphological and functional arterial changes are present in GDM. Diameter, intima-media thickness (IMT), intima-media cross-section area (IMCSA) and elasticity features (compliance, distensibility coefficient, circumferential strain, stiffness index (SI) α and β, incremental elastic modulus) of the common carotid arteries (CCA) were studied in the 3rd trimester in 25 women with GDM, and 17 normal pregnant women matched for age and body mass index using an ultrasonographic vessel wall-movement tracking system and applanation tonometry. Mean IMT, IMCSA and SI α tended to be larger, whereas compliance was smaller in women with GDM but none of these differences were significant. Serum glucose (4.99 ± 0.51 vs. 4.79 ± 0.61 mmol/L, p=0.37) and HbA1c (5.33 ± 0.27 vs. 5.36 ± 0.47 mmol/L, p=0.85) proved normoglycemia in both groups. In conclusion, by the combination of methods we applied in this case control study, neither morphological nor functional characteristics of large elastic arteries differ significantly between well-treated normoglycemic women with GDM and non-diabetic pregnant women in the 3rd trimester.
Collapse
Affiliation(s)
- Ildikó Vastagh
- Department of Neurology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
| | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Abstract
Diabetes mellitus and depression are public health concerns of the present and, as predicted, also the future. The observation that depression is seen more frequently in diabetic patients compared to the non-diabetic population has been proven by several recent studies. The co-occurrence carries further risks for the affected patients, as depression in diabetics may affect sufficient treatment of diabetes and enhance the development of diabetic complications. These may further worsen depressive symptoms causing a vicious cycle in these patients. In the present paper authors discuss in detail the theoretic and practical issues of the complex two directional relationships between diabetes and depression. Their goal is to draw attention to depression as co-morbidity of diabetes that may interfere with the optimization of diabetic patient's carbohydrate metabolism. If sufficient glycaemic control is not achieved using routine clinical methods depression should be evaluated as a probable cause. If needed, depression should be treated to improve the medical outcomes and quality of life of diabetic patients.
Collapse
Affiliation(s)
- Géza Nagy
- Semmelweis Egyetem, Általános Orvostudományi Kar II. Belgyógyászati Klinika Budapest Szentkirályi u. 46. 1088.
| | | | | | | | | |
Collapse
|
20
|
Rosta K, Molvarec A, Enzsöly A, Nagy B, Rónai Z, Fekete A, Sasvári-Székely M, Rigó J, Vér A. Association of extracellular superoxide dismutase (SOD3) Ala40Thr gene polymorphism with pre-eclampsia complicated by severe fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 2008; 142:134-8. [PMID: 19108943 DOI: 10.1016/j.ejogrb.2008.10.014] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2008] [Revised: 10/10/2008] [Accepted: 10/22/2008] [Indexed: 02/07/2023]
Abstract
OBJECTIVE Placental and systemic oxidative stress with an imbalance in the oxidant/antioxidant activity seems to play a central role in the pathogenesis of pre-eclampsia. The aim of our study was to examine whether two missense polymorphisms of the extracellular superoxide dismutase (SOD3) gene (Arg213Gly and Ala40Thr) are associated with pre-eclampsia in a Caucasian population from Hungary. STUDY DESIGN One hundred and fifty-nine pre-eclamptic patients and 114 normotensive, healthy pregnant women were involved in this case-control study. The SOD3 Arg213Gly and Ala40Thr genotypes were determined using the polymerase chain reaction-restriction length polymorphism (PCR-RFLP) and allele-specific amplification methods. RESULTS The Arg213Gly variant was not detected in our population. There were no significant differences in the genotype and allele frequencies of the SOD3 Ala40Thr polymorphism between pre-eclamptic patients and control subjects. However, the mutant allele carriers of this polymorphism showed an increased risk for severe fetal growth restriction-complicated pre-eclampsia, which was independent of maternal age, prepregnancy BMI, primiparity and smoking status (OR: 6.07, 95% CI: 1.33-27.8, p=0.020; adjusted OR: 4.89, 95% CI: 1.03-23.2, p=0.046). CONCLUSION Our results suggest a role of SOD3 Ala40Thr single nucleotide polymorphism in the risk of severe fetal growth restriction-complicated pre-eclampsia. However, further studies are needed with a larger sample size to confirm our findings and to explore the exact molecular basis of this observation.
Collapse
Affiliation(s)
- Klára Rosta
- Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary
| | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Molvarec A, Vér A, Fekete A, Rosta K, Derzbach L, Derzsy Z, Karádi I, Rigó J. Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia. Hypertens Res 2007; 30:205-11. [PMID: 17510501 DOI: 10.1291/hypres.30.205] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Associations have been reported between estrogen receptor alpha (ESR1) gene polymorphisms and various pathological conditions, including cardiovascular diseases. Our aim was to investigate whether two polymorphisms of the ESR1 gene (ESR1 c.454 -397T>C: PvuII restriction site and c.454 -351A>G: XbaI restriction site) are associated with preeclampsia. In a case-control study, we analyzed blood samples from 119 severely preeclamptic patients and 103 normotensive, healthy pregnant women using the polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method. All of the women were Caucasian. There was no association between severe preeclampsia and the PvuII and XbaI ESR1 gene polymorphisms separately. However, with the simultaneous carriage of both polymorphisms, the TT/AA genotype combination was significantly more frequent in severely preeclamptic patients than in healthy control subjects (24.4% vs. 9.7%, p=0.003), whereas the TT/AG combination was significantly less frequent in the severely preeclamptic group than in the control group (5.0% vs. 18.4%, p=0.002). According to the haplotype estimation, the homozygous T-A haplotype carriers had an increased risk of severe preeclampsia independent of maternal age, prepregnancy BMI, primiparity and smoking status (adjusted odds ratio [OR]: 4.36, 95% confidence interval [CI]: 1.65-11.53). The GG genotype of the XbaI polymorphism was associated with a lower risk of fetal growth restriction in patients with severe preeclampsia (OR: 0.23, 95% CI: 0.07-0.73). In conclusion, the homozygous T-A haplotype carriers of ESR1 PvuII and XbaI polymorphisms showed an increased risk of severe preeclampsia. In addition, the GG genotype of the XbaI polymorphism decreased the risk of fetal growth restriction in severely preeclamptic patients.
Collapse
Affiliation(s)
- Attila Molvarec
- Department of Obstetrics and Gynecology, Kútvölgyi Clinical Center, Semmelweis University, Budapest, Hungary.
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Rosta K. [Conference about the significance of patient education in diabetes mellitus]. Orv Hetil 2007; 148:813. [PMID: 17557380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
|
23
|
Abstract
Chemical reactions, including oxidation and reduction of molecules, occur in every cell. These reactions can lead to the production of free radicals. Free radicals react with organic substrates such as lipids, proteins, and DNA. Through oxidation free radicals cause damage to these molecules, disturbing their normal function, and may therefore contribute to a variety of diseases. The anti-oxidation system, which consists of enzymatic antioxidants and non-enzymatic antioxidants, defends against oxidative stress. The aim of this review is to summarize general aspects of methods to measure the antioxidant defence system all in one (total antioxidant capacity) and discuss a number of methods which are currently used for detection of antioxidant properties.
Collapse
Affiliation(s)
- Anikó Somogyi
- 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
| | | | | | | | | |
Collapse
|
24
|
Abstract
Variants of the leptin receptor gene (LEPR) may modulate the effect of elevated serum leptin levels in pre-eclampsia. The aim of our study was to evaluate the LEPR gene polymorphisms Lys109Arg (A109G) and Gln223Arg (A223G) in severely pre-eclamptic women. In a case-control study, we analyzed blood samples from 124 severely pre-eclamptic patients and 107 healthy control women by the polymerase chain reaction-restriction fragment length polymorphism method. The Pearson chi2 test was used to estimate odds ratios (OR) and 95% confidence intervals (CI). The association was adjusted for maternal age, pre-pregnancy body mass index and primiparity with logistic regression analysis. Pregnant women with the LEPR 223G allele (223A/G or 223G/G genotype) had almost double the risk of developing severe pre-eclampsia compared with patients with the 223A/A genotype (adjusted OR = 1.92, 95% CI: 1.07-3.41). Genotype variants of LEPR A109G alone did not affect the risk of severe pre-eclampsia. Haplotype estimation of A109G and A223G polymorphisms of the LEPR gene revealed that the G-A haplotype versus other pooled haplotypes was significantly less common in the pre-eclamptic group (p < 0.01), while the G-G haplotype versus others was overrepresented among severely pre-eclamptic patients (p < 0.01), compared with controls. In conclusion, our data indicate that LEPR A223G polymorphism may individually modify the risk of severe pre-eclampsia.
Collapse
Affiliation(s)
- János Rigó
- First Department of Obstetrics and Gynaecology, Semmelweis University, Budapest, Hungary.
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Somogyi A, Ruzicska E, Blázovics A, Vér A, Rosta K, Tóth M. Insulin treatment decreases the antioxidant defense mechanism in experimental diabetes. Med Sci Monit 2005; 11:BR206-11. [PMID: 15990681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2004] [Accepted: 01/18/2005] [Indexed: 05/03/2023] Open
Abstract
BACKGROUND Hyperglycemia-induced oxidative stress and left ventricular hypertrophy is an independent risk factor for cardiovascular disease. Our aim was to determine the relationship between left ventricular hypertrophy and the total scavenger capacity (TSC) in diabetic rats. MATERIAL/METHODS Control animals (n=30) were compared to streptozotocin-induced diabetic rats (n=38) and diabe-tic rats receiving insulin treatment (n=30) for 22 days. Half of the animals received angiotensin II on day 21. The left ventricular mass, TSC and carbohydrate parameters were determined. RESULTS Diabetes did not alter left ventricular mass; however, diabetes with insulin treatment was associated with left ventricular hypertrophy. The extent of ventricular hypertrophy did not change significantly in this group after angiotensin II treatment. TSC increased very significantly in diabetic rats. These differences remained high when angiotensin II-treated control rats [CA] were compared with treated diabetic rats [DA] (p<0.005). TSC decreased significantly when diabetic rats were treated with insulin. CONCLUSIONS Diabetes results in oxidative stress, which in turn enhances the activity of antioxidant enzymes. This increase in enzyme activity inhibits the subcellular remodeling processes, thus also inhibiting concomitant cardiac hypertrophy. Insulin treatment decreases the activity of the antioxidant system and can enhance the function of other localized tissue-specific growth factors. These changes may contribute to the early onset of cardiovascular damage detected in diabetic patients.
Collapse
Affiliation(s)
- Anikó Somogyi
- 2nd Department of Medicine, Semmelweis University, Budapest, Hungary.
| | | | | | | | | | | |
Collapse
|
26
|
Somogyi J, Szalay J, Pándics T, Rosta K, Csermely P, Vér A. [New steroid hormone family: endogenous cardiac glycosides and their role in physiologic and pathologic conditions]. Orv Hetil 2004; 145:259-66. [PMID: 15038319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/29/2023]
Abstract
In the last two decades extensive study has been carried out on the isolation, identification and biosynthesis of the "endogenous digitalis-like compounds" whose physiological and pathophysiological functions are only starting to be understood. Besides ouabain (strophanthin) and digoxin, four further endogenous cardiac glycosides were isolated and identified so far. These compounds are found in almost all mammalian tissues, including blood plasma and urine, but with the highest concentrations in the adrenal gland, pituitary and hypothalamus. De novo biosynthesis of these glycosides occurs in zona fasciculata cells of adrenal glands, precursors such as progesterone, pregnenolone, and rhamnose increase the synthesis of the ouabain-like immunoreactive material. The secretion of these compounds from the adrenocortical cells are controlled by adrenerg mechanisms, as well as via the renin-angiotensin system. The hydrophobic cardiac glycosides are transported in blood as complexes bound to specific binding globulins. The identified endogenous cardiac glycosides fulfill all the postulated criterions of the hormones, so they represent a new class of steroid hormones. The cardiac glycosides influence the active sodium pump, indirectly the intracellular free calcium concentration and therefore exert a positive inotropic effect on cardiac muscle. Furthermore, in physiological concentrations they can regulate the cell growth and protein synthesis inducing activation of intracellular signal pathways. Under pathological conditions, however, when the concentration of these steroids are high, they play a crucial role in the development of different serious illnesses such as essential hypertension as well as congestive heart failure. Further intensive investigations are needed to clarify some contradictory details accumulated during the last few years in this field.
Collapse
Affiliation(s)
- János Somogyi
- Semmelweis Egyetem, Altalános Orvostudományi Kar, Orvosi Vegytani, Molekuláris Biológiai és Pathobiokémiai Intézet, Budapest
| | | | | | | | | | | |
Collapse
|